Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Short-term Investments (2022 - 2025)

Biofrontera has reported Short-term Investments over the past 4 years, most recently at $9000.0 for Q4 2025.

  • For Q4 2025, Short-term Investments rose 28.57% year-over-year to $9000.0; the TTM value through Dec 2025 reached $9000.0, up 28.57%, while the annual FY2025 figure was $9000.0, 28.57% up from the prior year.
  • Short-term Investments for Q4 2025 was $9000.0 at Biofrontera, down from $10000.0 in the prior quarter.
  • Over five years, Short-term Investments peaked at $10.5 million in Q4 2022 and troughed at $7000.0 in Q4 2024.
  • A 4-year average of $1.8 million and a median of $10000.0 in 2024 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: crashed 99.76% in 2024 and later grew 28.57% in 2025.
  • Year by year, Short-term Investments stood at $10.5 million in 2022, then plummeted by 99.26% to $78000.0 in 2023, then crashed by 91.03% to $7000.0 in 2024, then grew by 28.57% to $9000.0 in 2025.
  • Business Quant data shows Short-term Investments for BFRI at $9000.0 in Q4 2025, $10000.0 in Q3 2025, and $9000.0 in Q2 2025.